Michael F Mahoney Boston Scientific Corp (BSX) insider trading activity

Michael F Mahoney is Chairman, President & CEO of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 1.65 Million shares of BSX, which is worth approximately $168 Million. The most recent transaction as insider was on Feb 14, 2024, when has been sold 16,523 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.65M

8.69% 3M change

1.23% 12M change

Total Value Held $168 Million

Michael F Mahoney Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 14 2024	BUY Exercise of conversion of derivative security	-	16,523 Added 0.99%	1,652,879 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	-	65,047 Reduced 3.82%	1,636,356 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	146,666 Added 7.94%	1,701,403 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$2,318,412 $57.81 p/Share	40,104 Reduced 2.51%	1,554,737 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	95,919 Added 5.67%	1,594,841 Common Stock
Nov 06 2023	SELL Open market or private sale	$5,952,323 $52.51 p/Share	113,356 Reduced 7.03%	1,498,922 Common Stock
Nov 06 2023	BUY Exercise of conversion of derivative security	$1,666,333 $14.7 p/Share	113,356 Added 6.57%	1,612,278 Common Stock
Oct 09 2023	SELL Open market or private sale	$5,904,661 $52.09 p/Share	113,355 Reduced 7.03%	1,498,922 Common Stock
Oct 09 2023	BUY Exercise of conversion of derivative security	$1,666,318 $14.7 p/Share	113,355 Added 6.57%	1,612,277 Common Stock
Sep 12 2023	SELL Open market or private sale	$6,110,968 $53.91 p/Share	113,355 Reduced 7.03%	1,498,922 Common Stock
Sep 12 2023	BUY Exercise of conversion of derivative security	$1,666,318 $14.7 p/Share	113,355 Added 6.57%	1,612,277 Common Stock
Aug 30 2023	SELL Bona fide gift	-	318,218 Reduced 17.51%	1,498,922 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$344,968 $46.23 p/Share	7,462 Reduced 0.4%	1,850,840 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	16,825 Added 0.9%	1,858,302 Common Stock
Feb 18 2023	SELL Payment of exercise price or tax liability	$336,623 $46.54 p/Share	7,233 Reduced 0.39%	1,841,477 Common Stock
Feb 18 2023	BUY Exercise of conversion of derivative security	-	16,307 Added 0.87%	1,848,710 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$378,416 $46.54 p/Share	8,131 Reduced 0.44%	1,832,403 Common Stock
Feb 17 2023	BUY Exercise of conversion of derivative security	-	18,333 Added 0.99%	1,840,534 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$335,306 $46.48 p/Share	7,214 Reduced 0.39%	1,822,201 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	16,264 Added 0.88%	1,829,415 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$387,115 $47.29 p/Share	8,186 Reduced 0.45%	1,813,151 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	-	18,457 Added 1.0%	1,821,337 Common Stock
Jan 01 2023	SELL Payment of exercise price or tax liability	$1,044,591 $46.27 p/Share	22,576 Reduced 1.24%	1,802,880 Common Stock
Jan 01 2023	BUY Exercise of conversion of derivative security	-	57,791 Added 3.07%	1,825,456 Common Stock
Nov 07 2022	SELL Open market or private sale	$5,280,959 $41.97 p/Share	125,827 Reduced 6.65%	1,767,665 Common Stock

Also insider at

BAX

BAXTER INTERNATIONAL INC Healthcare

Director

CVS

CVS HEALTH Corp Healthcare

Director

MFM